FDA reviews Actos drug for bladder cancer risk
Links shared publicly online about this topic.
- 865total visits
FDA reviews Actos drug for bladder cancer risk
View full resource at news-medical.net
Tags: Diabetes Type 2 Medication, Diabetes Medication, Bladder Cancer, Urinary System, Drug, FDA, Actos
Most Recently Shared on September 18, 2010 at 4:29 am By:
FDA reviews Actos drug for bladder cancer risk: The U.S. Food and Drug Administration today announced it has begun... http://bit.ly/bKwtuu
FDA OKs stronger warning for diabetes drug pioglitazone - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA authorized an updated label for diabetes medicines containing pioglitazone, such as Takeda Pharmaceutical's Actos, that includes data on increased risk of bladder cancer in patients treated for more than one year. Also, clinicians are advised against giving such drugs to patients with activ…” View full resource at smartbrief.com
Most Recently Shared on August 8, 2011 at 4:14 pm By:
#FDA OKs stronger #warning for #diabetes drug pioglitazone http://t.co/FzFVw6v #endo
Pioglitazone Gets New Cancer Risk Labeling - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at qualitypointtech.net
Most Recently Shared on August 5, 2011 at 9:01 pm By:
Pioglitazone Gets New Cancer Risk Labeling: (MedPage Today) -- Following a warning about bladder cancer risk, the ... http://bit.ly/nUzwEf
Medical News: Pioglitazone Gets New Cancer Risk Labeling - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2011 at 8:49 pm By:
Pioglitazone Gets New Cancer Risk Labeling http://bit.ly/rni8ws
Medical News: Pioglitazone Gets New Cancer Risk Labeling - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2011 at 8:47 pm By:
Pioglitazone Gets New Cancer Risk Labeling http://bit.ly/rhlnZi
FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines - Drugs.com MedNews
drugs.com — “This update provides a follow-up to the Drug Safety Communication Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer1” View full resource at drugs.com
Most Recently Shared on August 5, 2011 at 1:06 pm By:
Drugs and Devices OW OW Health
FDA Drug Safety Communication: Updated drug labels for pioglitazone-containing medicines: This update prov... http://bit.ly/pFG8cj #drug
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says | The Japan Times Online
search.japantimes.co.jp — “Takeda Pharmaceutical Co.'s Actos diabetes drug may be kept on the market with new warnings, the European Medicines Agency said after reviewing research showing the drug carried a slightly increased risk of bladder cancer.” View full resource at search.japantimes.co.jp
Most Recently Shared on July 23, 2011 at 12:52 am By:
Takeda's Actos diabetes pill needs new cancer-risk warning, Europe says: Takeda Pharmaceutical Co.'s Actos diabe... http://bit.ly/nk7vkg
FDA Reviewers Flag Cancer Risk in Diabetes Drug - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- FDA reviewers said the novel diabetes drug dapagliflozin appears effective at treating diabetes, but may pose breast and bladder cancer risks as well as liver toxicity.” View full resource at qualitypointtech.net
Most Recently Shared on July 15, 2011 at 8:45 pm By:
FDA Reviewers Flag Cancer Risk in Diabetes Drug: WASHINGTON (MedPage Today) -- FDA reviewers said the novel diabet... http://bit.ly/pfGeXy
Medical News: FDA Reviewers Flag Cancer Risk in Diabetes Drug - in Cardiovascular, Diabetes from MedPage Today
medpagetoday.com — “WASHINGTON -- FDA reviewers said the novel diabetes drug dapagliflozin appears effective at treating diabetes, but may pose breast and bladder cancer risks as well as liver toxicity.” View full resource at medpagetoday.com
Most Recently Shared on July 15, 2011 at 8:31 pm By:
FDA Reviewers Flag Cancer Risk in Diabetes Drug http://bit.ly/qVUQUc
Medical News: ADA: FDA Unlikely to Zap Pioglitazone - in Meeting Coverage, ADA from MedPage Today
medpagetoday.com — “SAN DIEGO -- Bladder cancer risks aren't likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to this exclusive InFocus report from the Americ” View full resource at medpagetoday.com
Most Recently Shared on June 26, 2011 at 8:54 pm By:
ADA: FDA Unlikely to Zap Pioglitazone (with video) http://bit.ly/iy2WkY
Longer-term use of pioglitazone associated with an increased risk of bladder cancer - - Drug Topics
drugtopics.modernmedicine.com — “FDA published an online safety communication on June 15, informing prescribers and patients that pioglitazone (Actos, Takeda Pharmaceuticals America Inc., Deerfield, Illinois) use may be associated with a 20% to 40% increased hazard of new bladder cancer.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on June 22, 2011 at 8:37 pm By:
Drugs and Devices OW OW Health
Longer-term use of pioglitazone associated with an increased risk of bladder cancer: FDA published an online saf... http://bit.ly/myRyc6
Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone) - American Diabetes Association
t.co — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” View full resource at t.co
Most Recently Shared on June 20, 2011 at 3:59 pm By:
Kelly / Diabetes Patient Expert
RT @HopeWarsha Response to FDA's 6/15 statement on Actos from ADA, Endo Society & AACE http://t.co/rArN4rc. Nice to see one clear message!
Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone) - American Diabetes Association
diabetes.org — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” View full resource at diabetes.org
Most Recently Shared on June 20, 2011 at 3:56 pm By:
Hope Warshaw Nutritionist and Dietitian
Combined response to FDA's 6/15 statement on Actos from ADA, Endo Society and AACE http://bit.ly/mLk1bq. How nice to see one clear message!
Diabetes Drug Actos May Raise Risk for Bladder C... ( By Steven Reinberg HealthDay Rep...)
bio-medicine.org — “Health, By Steven Reinberg HealthDay Reporter ...THURSDAY June 16 (HealthDay News) -- The U.S. Food and Drug Administr...The agency's warning comes five days after Germany and France pulled A...The new cancer warning will appear on the labeling the FDA said. ...However although Actos does have some side effects the beneficial e...,Diabetes,Drug,Actos,May,Raise,Risk,for,Bladder,Cancer:,FDA,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine new” View full resource at bio-medicine.org
Most Recently Shared on June 18, 2011 at 1:14 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA http://bit.ly/iuGELw
FDA, medical societies warn of possible link between diabetes drug, bladder cancer risk | HemOncToday
hemonctoday.com — “After reviewing data from a 5-year interim analysis of an ongoing, 10-year epidemiological study, the FDA is informing the public of a possible” View full resource at hemonctoday.com
Most Recently Shared on June 17, 2011 at 7:51 pm By:
HemOnc Today Health News and Oncology
#FDA, medical societies warn of possible link between #diabetes drug, bladder cancer risk http://t.co/aHMiBBC
FDA updates safety review of pioglitazone & risk of bladder cancer
newsroom.heart.org — “AHA Comment” View full resource at newsroom.heart.org
Most Recently Shared on June 17, 2011 at 3:04 pm By:
FDA updates ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer: American Heart A... http://bit.ly/iFWPhD
Advertisement
